Feasibility of Urgent-Start Peritoneal Dialysis in Older Patients with End-Stage Renal Disease: A Single-Center Experience

医学 腹膜透析 透析 血液透析 终末期肾病 单中心 优势比 回顾性队列研究 外科 内科学 肾脏疾病 导管 肾病科 入射(几何) 物理 光学
作者
Haijiao Jin,Zhaohui Ni,Shan Mou,Renhua Lu,Wei Fang,Jiaying Huang,Chunhua Hu,Zhang Hai-fen,Hao Yan,Zhenyuan Li,Zanzhe Yu
出处
期刊:Peritoneal Dialysis International [SAGE Publishing]
卷期号:38 (2): 125-130 被引量:26
标识
DOI:10.3747/pdi.2017.00002
摘要

Background Patients with end-stage renal disease (ESRD) frequently require urgent-start dialysis. Recent evidence suggests that peritoneal dialysis (PD) might be a feasible alternative to hemodialysis (HD) in these patients, including in older patients. Methods This retrospective study enrolled patients aged > 65 years with ESRD who underwent urgent dialysis without functional vascular access or PD catheter at a single center, from January 2011 to December 2014. Patients were grouped based on their dialysis modality (PD or HD). Patients unable to tolerate PD catheter insertion or wait for PD were excluded. Each patient was followed for at least 30 days after catheter insertion. Short-term (30-day) dialysis-related complications and patient survival were compared between the 2 groups. Results A total of 94 patients were enrolled, including 53 (56.4%) who underwent PD. The incidence of dialysis-related complications during the first 30 days was significantly lower in PD compared with HD patients (3 [5.7%] vs 10 [24.4%], p = 0.009). Logistic regression identified urgent-start HD as an independent risk factor for dialysis-related complications compared with urgent-start PD (odds ratio 4.760 [1.183 – 19.147], p = 0.028). The 6-, 12-, 24-, and 36-month survival rates in the PD and HD groups were 92.3% vs 94.6%, 82.4% vs 81.3%, 75.7% vs 74.2%, and 69.5% vs 60.6%, respectively, with no significant differences between the groups (log-rank = 0.011, p = 0.915). Conclusion Urgent-start PD was associated with fewer short-term dialysis-related complications and similar survival to urgent-start HD in older patients with ESRD. Peritoneal dialysis may thus be a safe and effective dialysis modality for older ESRD patients requiring urgent dialysis.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
杨勇5926193662完成签到,获得积分10
1秒前
1秒前
冷艳代萱完成签到 ,获得积分10
1秒前
知安发布了新的文献求助10
1秒前
Huangshuishui完成签到,获得积分10
2秒前
小蘑菇应助可爱花瓣采纳,获得10
2秒前
狂魔春笋完成签到,获得积分20
2秒前
2秒前
蔡徐坤完成签到,获得积分10
2秒前
2秒前
3秒前
脑洞疼应助优雅的不惜采纳,获得10
3秒前
4秒前
4秒前
yanning完成签到,获得积分10
4秒前
瘦瘦的老三完成签到,获得积分10
4秒前
1001发布了新的文献求助10
5秒前
傻子与白痴完成签到,获得积分10
5秒前
Jasper应助wangjiale采纳,获得10
5秒前
无花果应助科研通管家采纳,获得10
6秒前
渤大小mn发布了新的文献求助10
6秒前
Abner应助科研通管家采纳,获得10
6秒前
6秒前
李健应助科研通管家采纳,获得10
6秒前
星河应助科研通管家采纳,获得10
7秒前
7秒前
Owen应助科研通管家采纳,获得20
7秒前
v0id应助科研通管家采纳,获得10
7秒前
情怀应助科研通管家采纳,获得10
7秒前
12完成签到,获得积分10
7秒前
7秒前
Li完成签到,获得积分10
7秒前
Abner应助科研通管家采纳,获得10
8秒前
斯文败类应助科研通管家采纳,获得10
8秒前
帅气碧萱应助科研通管家采纳,获得30
8秒前
华仔应助科研通管家采纳,获得10
8秒前
Orange应助科研通管家采纳,获得30
8秒前
沉默诗柳发布了新的文献求助10
8秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
HYDROLYSE ACIDE DE QUELQUES DIOXASPIROCYCLANES 1314
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 800
Navigating Normative Orders. Interdisciplinary Perspectives 800
1 Peter and Christ's Descent to the Dead in Its Early Christian Reception 700
Organizational Behavior 510
Management and the Arts 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7748524
求助须知:如何正确求助?哪些是违规求助? 9296564
关于积分的说明 20235589
捐赠科研通 7329682
什么是DOI,文献DOI怎么找? 3308895
关于科研通互助平台的介绍 2460570
邀请新用户注册赠送积分活动 2320932